B

Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC

Watchlist Manager
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
Watchlist
Price: 3.01 USD -57.3%
Market Cap: $58m

Bellevue Life Sciences Acquisition Corp
Cash

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Bellevue Life Sciences Acquisition Corp
Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
B
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
Cash
$15.4k
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WP Carey Inc
NYSE:WPC
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AltC Acquisition Corp
NYSE:OKLO
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Annaly Capital Management Inc
NYSE:NLY
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ares Capital Corp
NASDAQ:ARCC
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SoFi Technologies Inc
NASDAQ:SOFI
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bellevue Life Sciences Acquisition Corp
Glance View

Market Cap
58m USD
Industry
N/A

Bellevue Life Sciences Acquisition Corp. operates as a blank check company. The company is headquartered in Bellevue, Washington. The company went IPO on 2023-02-10. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The firm has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm may pursue an acquisition opportunity in any business industry or sector. The firm intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The firm neither engaged in any operations nor generated any revenues.

BLAC Intrinsic Value
Not Available

See Also

What is Bellevue Life Sciences Acquisition Corp's Cash?
Cash
15.4k USD

Based on the financial report for Dec 31, 2023, Bellevue Life Sciences Acquisition Corp's Cash amounts to 15.4k USD.

What is Bellevue Life Sciences Acquisition Corp's Cash growth rate?
Cash CAGR 3Y
-36%

Over the last year, the Cash growth was -87%. The average annual Cash growth rates for Bellevue Life Sciences Acquisition Corp have been -36% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett